- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Repeat Breast Surgeries an Unnecessary Burden on Patients, Survey Finds
A national survey published in JAMA Surgery identified too many repeat surgeries in women with breast cancer.
A large national review shows that about a quarter of women who opt for lumpectomy to preserve their breasts wind up having further surgery to reduce risk of the cancer returning.
And the reasons aren’t necessarily medical: repeat surgery rates are driven by factors such as demography and differences of opinion about how much cancer-free tissue make up an adequate surgical margin. The result is that some patients may needlessly have a second surgery.
“Past studies were too small and too regional to know the true national statistics,” says lead author Dr Lee Wilke, who directs the UW Health Breast Center at the UW Carbone Cancer Center. “Now we have a baseline, and while it declined slightly during the study period (from 25.4 to 23.7 percent) it is still too high. We’ll never get to zero but 10 percent is a reasonable goal.”
Read the complete article: http://bit.ly/1oRgPwK
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
